Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 581 posts found.

2022 Novo Holdings Seed Investments team Review/Business Update

January 24, 2023
Business Services

Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …

News
Press release

Global Company Foot Science International Choose Onyx Health

January 24, 2023
Business Services

Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …

News
Press release

Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

January 24, 2023
Business Services

Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Modus Therapeutics submits patent application for sevuparin in kidney disease

January 23, 2023
Business Services

STOCKHOLM, SWEDEN – 23 January 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …

News
Press release

Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)

January 23, 2023
Business Services

Dublin, Ireland – January 23, 2023 – Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound …

News
Press release

NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance

January 19, 2023
Business Services

MAIDENHEAD, UK, 19th January 2023 – Alnylam UK Limited, the leading RNA interference (RNAi) therapeutics company, today welcomed a draft …

News
Press release

Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium

January 19, 2023
Business Services

PARIS, France, and PRINCETON, N.J., January 19, 2023 – Servier and Taiho Oncology, Inc., today announced the release of data …

News
Press release

NeoPhore completes extension to Series B financing to further advance discovery pipeline

January 19, 2023
Business Services

Cambridge, UK, 19 January 2023 – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the completion of its £21.5m …

News
Press release

PFIZER EXPANDS ‘AN ACCORD FOR A HEALTHIER WORLD’ PRODUCT OFFERING TO INCLUDE FULL PORTFOLIO FOR GREATER BENEFIT TO 1.2 BILLION PEOPLE IN 45 LOWER-INCOME COUNTRIES

January 18, 2023
Business Services

DAVOS, Switzerland, January 17, 2023 – Pfizer Inc.

News
Press release

AstraZeneca UK, Qure.ai and Greater Manchester Cancer Alliance Join Forces to Battle Lung Cancer Waiting Times Using Artificial Intelligence (AI) Technology

January 17, 2023
Business Services

London, UK, 13 January 2023 – An initiative to improve earlier diagnosis of lung cancer has been launched by AstraZeneca UK, …

News
Press release

The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations

January 16, 2023
Business Services

16 January 2023, Feltham (Merck) – Today Merck, a leading science and technology company, announced that following a resubmission to …

News
Press release

Poolbeg announces strategic expansion of POLB 001 into oncology

January 16, 2023
Business Services

16 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …

News
Press release

finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV

January 13, 2023
Business Services

London, 9th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised the three …

News
Press release

Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma

January 11, 2023
Business Services

London, UK, 11 January 2023 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical …

News
Press release

Ovarian Cancer Commitment launches digital patient support resource for anyone affected by ovarian cancer

January 11, 2023
Business Services

28 October 2022, 10:00 BST

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025